Published on : Jun 11, 2018
Albany, New York, June 11, 2018: Market Research Hub (MRH) has actively published a new research study titled “Antiulcerant Drugs: Global Markets to 2022”, to its broad online repository with an aim to enlighten the readers about the prevailing trends across the global market in the near future. As per research findings, the growth projections experienced in the market includes rising disposable income across developed countries, rising awareness of the disease as well as technological advances like big data, IoT and 3D printing. Furthermore, the market for antiulcerant drugs reached an impressive billion dollar value in 2017 and is likely to grow at a surprising compound annual growth rate (CAGR) by 2020.
This research report is a smart compilation of data which works to inform the readers about the diverse factors impacting the global antiulcerant drugs market. Reporting of definition, types, causes, as well as treatment choices for ulcers are part of the study. Furthermore, the report classifies the antiulcerant drugs market by type, including H2 receptor antagonists, proton pump inhibitors, antibiotics, antacids, gastric mucosal protective drugs and prostaglandin agonists. Proton pump inhibitors acquired the largest share in the antiulcerant drugs market in 2017. However, the highest growth is anticipated to come from H2 receptor antagonists segment that is forecasted to grow remarkably during the forecast period till 2022. The prime factors for this growth include ageing population, increasing awareness about ulcer disease and sedentary lifestyles.
Considering the regional bifurcation, North America is known to acquire the largest market share for antiulcerant drugs; this particular region is further expected to acquire an impressive market share percentage in the coming years. Asia Pacific and Western Europe are the other leading regions that are anticipated to exhibit promising growth until 2022. Focusing on the country-wise segmentation, USA grabs the largest market based on value in the antiulcerant drugs market. Interestingly, India and China are forecasted to experience the fastest growth, rising at notable CAGR values. However, the concerned market is tested by restraints like rising trade protectionism and opposed laws for drug patents.
The final section of the report discusses the prominent players which are active in the antiulcerant drugs market. This report targets the manufacturers such as AstraZeneca PLC, Takeda Pharmaceutical Company, Daewoong Pharmaceutical Co., Ltd., Allergan plc, Eisai Co., Ltd and others. In addition, this research study offers a comprehensive profiling of every market player mentioned in the assessment. Furthermore, the inclusion of 97 data tables helps the readers in validating the researched data quite conveniently.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1803598
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org